TP53 and Ewing sarcoma: Because tumorigenesis is a complex process requiring multiple mutations, and because 10–15% of Ewing sarcoma patients have mutations in the tumor suppressor gene TP53, we chose to utilize the zebrafish tp53 mutant to evaluate the synergistic effect of ewsa and tp53 mutations.